Mainz Price Sales Ratio from 2010 to 2025

MYNZ Stock  USD 5.23  0.81  13.41%   
Mainz Biomed Price Sales Ratio yearly trend continues to be fairly stable with very little volatility. Price Sales Ratio will likely drop to 919.46 in 2025. During the period from 2010 to 2025, Mainz Biomed Price Sales Ratio regression line of annual values had r-squared of  0.73 and arithmetic mean of  11,646. View All Fundamentals
 
Price Sales Ratio  
First Reported
2010-12-31
Previous Quarter
967.85
Current Value
919.46
Quarterly Volatility
6.8 K
 
Credit Downgrade
 
Yuan Drop
 
Covid
Check Mainz Biomed financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Mainz Biomed's main balance sheet or income statement drivers, such as Tax Provision of 0.0, Depreciation And Amortization of 1.2 M or Interest Expense of 977.6 K, as well as many indicators such as Price To Sales Ratio of 919, Dividend Yield of 0.0 or PTB Ratio of 219. Mainz financial statements analysis is a perfect complement when working with Mainz Biomed Valuation or Volatility modules.
  
Check out the analysis of Mainz Biomed Correlation against competitors.

Latest Mainz Biomed's Price Sales Ratio Growth Pattern

Below is the plot of the Price Sales Ratio of Mainz Biomed BV over the last few years. It is Mainz Biomed's Price Sales Ratio historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Mainz Biomed's overall financial position and show how it may be relating to other accounts over time.
Price Sales Ratio10 Years Trend
Slightly volatile
   Price Sales Ratio   
       Timeline  

Mainz Price Sales Ratio Regression Statistics

Arithmetic Mean11,646
Geometric Mean7,870
Coefficient Of Variation58.77
Mean Deviation6,229
Median16,629
Standard Deviation6,845
Sample Variance46.9M
Range15.8K
R-Value(0.85)
Mean Square Error13.6M
R-Squared0.73
Significance0.000026
Slope(1,228)
Total Sum of Squares702.8M

Mainz Price Sales Ratio History

2025 919.46
2024 967.85
2023 841.61
2022 7588.04
2021 5190.71
2020 4539.73

About Mainz Biomed Financial Statements

Mainz Biomed investors use historical fundamental indicators, such as Mainz Biomed's Price Sales Ratio, to determine how well the company is positioned to perform in the future. Understanding over-time patterns can help investors decide on long-term investments in Mainz Biomed. Please read more on our technical analysis and fundamental analysis pages.
Last ReportedProjected for Next Year
Price Sales Ratio 967.85  919.46 

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

Additional Tools for Mainz Stock Analysis

When running Mainz Biomed's price analysis, check to measure Mainz Biomed's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Mainz Biomed is operating at the current time. Most of Mainz Biomed's value examination focuses on studying past and present price action to predict the probability of Mainz Biomed's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Mainz Biomed's price. Additionally, you may evaluate how the addition of Mainz Biomed to your portfolios can decrease your overall portfolio volatility.